Table of Contents

<< Previous Issue

Mar 2025 (Vol: 2025, Issue: 3)

Next Issue >>

Download pdf of entire issue

Section: Licensing
Biogen Gains Rights to Stoke Therapeutics’ Zorevunersen for the Treatment of Dravet Syndrome Published: 8 Mar-2025
By: Naini Anand
Abstract Fulltext:
AbbVie Enters Obesity Space Through US$2.2 B Licensing Pact with Gubra Published: 8 Mar-2025
By: Lucy Haggerty
Abstract Fulltext:
Roche Pays Zealand Pharma US$1.65 B Upfront for Obesity Drug Petrelintide Published: 14 Mar-2025
By: Lucy Haggerty
Abstract Fulltext:
Section: Mergers & Acquisitions
Sanofi to Acquire Dren Bio’s Autoimmune Bispecific Antibody for US$1.9 B Published: 27 Mar-2025
By: Lucy Haggerty
Abstract Fulltext:
Endo and Mallinckrodt Set to Unite Through a US$6.7 B Merger Published: 28 Mar-2025
By: Ayush Saxena
Abstract Fulltext:
Section: Opinion & Analysis
IQVIA Pharma Deals Review of 2024 Published: 21 Mar-2025
By: Lucy Haggerty,Taskin Ahmed,Ayush Saxena & Shikha Kashyap
Abstract Fulltext:
Section: Research & Development
Eli Lilly Signs US$1.2 B Collaboration with Magnet Biomedicine for Molecular Glue Therapeutics Published: 12 Mar-2025
By: Amit Kaushik
Abstract Fulltext:
Takeda Signs US$816 M Collaboration with BridGene Biosciences for Small Molecule Drugs Published: 17 Mar-2025
By: Amit Kaushik
Abstract Fulltext:

Login

Login

Username:

Password:

Keep me logged in

Login Problems? Subscribe

IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents